143 related articles for article (PubMed ID: 34707368)
1. Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study.
Chang B; Hwang IK; Lee SH
Onco Targets Ther; 2021; 14():5097-5106. PubMed ID: 34707368
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy.
Kwack WG; Sung JY; Lee SH
Front Oncol; 2021; 11():770230. PubMed ID: 34956890
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147
[TBL] [Abstract][Full Text] [Related]
4. Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study.
Kong M; Sung JY; Lee SH
Onco Targets Ther; 2019; 12():8263-8273. PubMed ID: 31632076
[TBL] [Abstract][Full Text] [Related]
5. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201
[TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study.
Kong M; Sung JY; Lee SH
Onco Targets Ther; 2020; 13():8173-8180. PubMed ID: 32904444
[TBL] [Abstract][Full Text] [Related]
7. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species modulator 1 expression predicts lymph node metastasis and survival in early-stage non-small cell lung cancer.
Kim T; Cha YJ; Park JH; Kim A; Choi YJ; Park HJ
PLoS One; 2020; 15(12):e0239670. PubMed ID: 33259495
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.
Lee SH; Park MJ; Choi SI; Lee EJ; Lee SY; In KH
Medicine (Baltimore); 2017 Jan; 96(4):e5975. PubMed ID: 28121949
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients.
Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Kim BH; Yoo YD; Oh SC
Onco Targets Ther; 2018; 11():4233-4246. PubMed ID: 30087567
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Lee HS; Kim BH; Lee SI; Min BW; Yoo YD; Oh SC
PLoS One; 2017; 12(5):e0176834. PubMed ID: 28472059
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
Zhang F; Wang J; Fu J; Hu L; Zheng X; Wang Y; Chen B
J Clin Lab Anal; 2020 Mar; 34(3):e23091. PubMed ID: 31709646
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
14. Increased Serum Romo1 Was Correlated with Lung Function, Inflammation, and Oxidative Stress in Chronic Obstructive Pulmonary Disease.
Ye L; Mao S; Fang S; Zhang J; Tan Y; Gu W
Inflammation; 2019 Oct; 42(5):1555-1560. PubMed ID: 31049771
[TBL] [Abstract][Full Text] [Related]
15. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer.
Ghasemi H; Amini MA; Pegah A; Azizi E; Tayebinia H; Khanverdilou S; Mousavibahar SH; Alizamir A
Mol Biol Rep; 2020 Sep; 47(9):6497-6505. PubMed ID: 32770525
[TBL] [Abstract][Full Text] [Related]
18. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
19. Serum Romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome.
Ye L; Qian Y; Li Q; Fang S; Yang Z; Tan Y; Gu W
Sleep Breath; 2018 Sep; 22(3):743-748. PubMed ID: 29302924
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
